Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476). (2022)

First Author: James ND
Attributed to:  Evaluating new healthcare technologies in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ijc.34018

PubMed Identifier: 35411939

Publication URI: http://europepmc.org/abstract/MED/35411939

Type: Journal Article/Review

Volume: 151

Parent Publication: International journal of cancer

Issue: 3

ISSN: 0020-7136